ImmunityBio resubmits cancer treatment application to FDA
Go back to ImmunityBio resubmits cancer treatment application to FDA| (NASDAQ: IBRX) | Delayed: 7.62 -0.3 (3.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.92 | 52 Week High | $ | |||
| Open | $7.79 | 52 Week Low | $ | |||
| Day High | $7.83 | P/E | N/A | |||
| Day Low | $7.54 | EPS | $ | |||
| Volume | 3,226,372 | |||||
